The renin-angiotensin system (RAS) and reactive oxygen species (ROS) have been implicated in the development of insulin resistance and its related complications. There is also evidence that angiotensin II (Ang II)-induced generation of ROS contributes to the development of insulin resistance in skeletal muscle, although the precise mechanisms remain unknown. In the present study, we found that Ang II markedly enhanced NADPH oxidase activity and consequent ROS generation in L6 myotubes. These effects were blocked by the angiotensin II type 1 receptor blocker losartan, and by the NADPH oxidase inhibitor apocynin. Ang II also promoted the translocation of NADPH oxidase cytosolic subunits p47 phox and p67 phox to the plasma membrane within 15 min. Furthermore, Ang II abolished insulin-induced tyrosine phosphorylation of insulin receptor substrate 1 (IRS1), activation of protein kinase B (Akt), and glucose transporter-4 (GLUT4) translocation to the plasma membrane, which was reversed by pretreating myotubes with losartan or apocynin. Finally, small interfering RNA (siRNA)-specific gene silencing targeted specifically against p47 phox (p47siRNA), in both L6 and primary myotubes, reduced the cognate protein expression, decreased NADPH oxidase activity, restored Ang II-impaired IRS1 and Akt activation as well as GLUT4 translocation by insulin. These results suggest a pivotal role for NADPH oxidase activation and ROS generation in Ang II-induced inhibition of insulin signaling in skeletal muscle cells.Insulin resistance and hypertension often coexist and frequently progress to diabetes and cardiovascular disease (1, 2). A reduced response by target tissues to insulin (3) is the hallmark of the metabolic syndrome (1-5), which is defined by a cluster of abnormalities including impaired glucose tolerance, hypertension, abdominal obesity, and dyslipidemia (6). Insulin signaling is a complex process involving multiple pathways and phosphorylation events. Phosphorylation of protein kinase B (Akt) is a key step leading to the translocation of glucose transporter 4 (GLUT4) 2 from intracellular compartments to the plasma membrane. GLUT4 helps mediate the increase in glucose uptake in skeletal muscle and adipose tissues in the presence of insulin (7,8). Skeletal muscle insulin receptor signaling is defective in metabolic syndrome and type 2 diabetes mellitus (T2DM) both in experimental models and humans (1-6;9). Many factors have been reported to induce insulin resistance in vitro and in vivo, including angiotensin II (Ang II), tumor necrosis factor (TNF)-␣, interleukin 6 (IL-6), and free fatty acids (10 -13).Ang II is an important physiological regulator of blood pressure, cardiac function, and salt and fluid homeostasis. Its hypertensive, growth, and remodeling effects are mediated through the Ang II receptor 1 (AT 1 R) (1, 5, 11). In addition, Ang II appears to be antagonistic to insulin action and contributes to insulin resistance. Several prospective clinical studies have shown that treating hypertensive patients with angiote...